PRESS RELEASE published on 09/29/2023 at 07:25, 1 year 1 month ago Spexis provides business update and announces financial results for the first half of 2023
PRESS RELEASE published on 09/28/2023 at 07:30, 1 year 1 month ago Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology
PRESS RELEASE published on 08/15/2023 at 07:25, 1 year 3 months ago Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies
PRESS RELEASE published on 07/18/2023 at 12:26, 1 year 4 months ago Original-Research: Spexis AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 06/30/2023 at 07:15, 1 year 4 months ago Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions
PRESS RELEASE published on 06/26/2023 at 17:31, 1 year 4 months ago Spexis announces the results of its Annual General Meeting 2023
PRESS RELEASE published on 06/07/2023 at 07:30, 1 year 5 months ago Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances
PRESS RELEASE published on 05/30/2023 at 07:15, 1 year 5 months ago Spexis provides business update and announces financial results for the full year 2022
PRESS RELEASE published on 04/28/2023 at 07:20, 1 year 6 months ago Spexis has received temporary approval of an extension until 31 of May 2023 for the disclosure obligation in connection with the publication and the filing of the annual report 2022.
PRESS RELEASE published on 04/18/2023 at 07:15, 1 year 7 months ago Spexis announces closing of capital commitment of USD 4.5 million from SPRIM Global Investments (SGI) to enable initiation of ColiFin® Phase 3 study
Published on 11/21/2024 at 16:30, 1 hour 1 minute ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 30 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 31 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 31 minutes ago Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 31 minutes ago Isaac Ullatil Joins Wellstack Board of Directors
Published on 11/21/2024 at 15:41, 1 hour 49 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 2 hours 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 2 hours 8 minutes ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 2 hours 9 minutes ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 06:58, 10 hours 33 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 11 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 23 hours 46 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 23 hours 46 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 9 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
